Cardioprotective effects of incretin during ischaemia-reperfusion.

@article{Chinda2012CardioprotectiveEO,
  title={Cardioprotective effects of incretin during ischaemia-reperfusion.},
  author={Kroekkiat Chinda and Siriporn C Chattipakorn and Nipon Chattipakorn},
  journal={Diabetes & vascular disease research},
  year={2012},
  volume={9 4},
  pages={256-69}
}
Incretin is a gut derived peptide hormone secreted in the intestine after food ingestion, and is degraded rapidly after secretion by dipeptidyl peptidase (DPP)-4. Incretin-based therapy, such as glucagon-like peptide (GLP)-1 and the DPP-4 inhibitor, has been proposed as a new therapeutic approach for the treatment of type 2 diabetic patients. In the past few years, growing evidence also demonstrated the cardioprotective effects of incretin-based therapy, especially during ischaemia-reperfusion… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Similar Papers

Loading similar papers…